monde (1) temps (durée) (1) thérapie (1) société (humaine) (1) simulation (1) risque (1) lipide (1) plomb (1) Europe (1) effet (1) dosage (1) cardiologie (1) Europe (1) Dose-response relationship (1) Treatment (1) Prevention (1) Inhibitors (1) Apoptosis (1) States (1) Rates (1) Time (1) Therapeutics (1) Syndromes (1) Swiss (1) Societies (1) Risk (1) Proportion (1) Patients (1) Manufacturers' agents (1) Human beings (1)